Clinical Pharmacology
Exam 1 Questions and
Answers Updated 2026
PharmacyB-BAnswerBTheBpreparationBandBdispensingBofBdrugs
PharmacognosyB-
BAnswerBTheBstudyBofBdrugsBthatBareBobtainedBfromBnaturalBplantBandBanimalBsourc
es.
PharmacogeneticsB-
BAnswerBTheBstudyBofBtheBinterrelationshipBofBgeneticBdifferencesBandBdrugBeffects
TherapeuticsB-BAnswerBTheBartBofBtreatingBdiseaseBwithBdrugs
ToxicologyB-
BAnswerBTheBstudyBofBtoxicBsubstancesBandBtheirBpharmacologicBactions,BincludingBa
ntidotesBandBpoisonBcontrol
ChemicalBnameB-BAnswerBTheBnameBindicatingBtheBdrug'sBchemicalBstructure.
CodeBnameB-
BAnswerBABnameBassignedBbyBaBmanufacturerBtoBanBexperimentalBchemicalBthatBsho
wsBpotentialBasBaBdrug.
GenericBnameB-
BAnswerBTheBnameBassignedBtoBaBchemicalBbyBtheBUnitedBStatesBAdoptedBNameB(U
SAN)BCouncilBwhenBtheBchemicalBappearsBtoBhaveBtherapeuticBuseBandBtheBmanufact
urerBwishesBtoBmarketBtheBdrug.
, TheBgenericBnameBisBalsoBknownBasBtheBnonproprietaryBname,BinBcontrastBtoBtheBbr
andBname.
OfficialBnameB-BAnswerBTheBgenericBnameBbecomesBtheBofficialBname
TradeBnameB-
BAnswerBThisBisBtheBbrandBn'ame,BorBproprietaryBname,BgivenBbyBaBparticularBmanu
facturer.
ChemicalBsynthesisB-BAnswerBMostBcommonBsourceBofBdrugBpreparation
PhaseB1BofBDrugBapprovalB-BAnswerBSmallBnumber,BhealthyBsubjects
PhaseB2BofBDrugBapprovalB-BAnswerBSmallBnumber,BsubjectsBwithBdisease
PhaseB3BofBDrugBapprovalB-BAnswerBLarge,BmultiBcenterBstudies
FDABapprovalBofBOrphanBDrugB-
BAnswerBABdrugBorBbiologicalBproductBforBtheBdiagnosisBorBtreatmentBofBaBrareBdise
ase
ABrareBdisease
DiseaseBaffectsB<200,000Bpersons
Also,BorphanBdrugBifBthereBisBnoBreasonableBexpectationBofBrecoveringBtheBcostBofBd
rugBdevelopment
RoutesBofBAdministrationB-
BAnswerBEnteral:Btablet,Bcapsule,Bsuppository,Belixir,Bsuspension
Parenteral:BIV,BIM,BSC,BIT,BIO
Transdermal:BPatch,Bpaste
Inhalation:BGas,Baerosol
Exam 1 Questions and
Answers Updated 2026
PharmacyB-BAnswerBTheBpreparationBandBdispensingBofBdrugs
PharmacognosyB-
BAnswerBTheBstudyBofBdrugsBthatBareBobtainedBfromBnaturalBplantBandBanimalBsourc
es.
PharmacogeneticsB-
BAnswerBTheBstudyBofBtheBinterrelationshipBofBgeneticBdifferencesBandBdrugBeffects
TherapeuticsB-BAnswerBTheBartBofBtreatingBdiseaseBwithBdrugs
ToxicologyB-
BAnswerBTheBstudyBofBtoxicBsubstancesBandBtheirBpharmacologicBactions,BincludingBa
ntidotesBandBpoisonBcontrol
ChemicalBnameB-BAnswerBTheBnameBindicatingBtheBdrug'sBchemicalBstructure.
CodeBnameB-
BAnswerBABnameBassignedBbyBaBmanufacturerBtoBanBexperimentalBchemicalBthatBsho
wsBpotentialBasBaBdrug.
GenericBnameB-
BAnswerBTheBnameBassignedBtoBaBchemicalBbyBtheBUnitedBStatesBAdoptedBNameB(U
SAN)BCouncilBwhenBtheBchemicalBappearsBtoBhaveBtherapeuticBuseBandBtheBmanufact
urerBwishesBtoBmarketBtheBdrug.
, TheBgenericBnameBisBalsoBknownBasBtheBnonproprietaryBname,BinBcontrastBtoBtheBbr
andBname.
OfficialBnameB-BAnswerBTheBgenericBnameBbecomesBtheBofficialBname
TradeBnameB-
BAnswerBThisBisBtheBbrandBn'ame,BorBproprietaryBname,BgivenBbyBaBparticularBmanu
facturer.
ChemicalBsynthesisB-BAnswerBMostBcommonBsourceBofBdrugBpreparation
PhaseB1BofBDrugBapprovalB-BAnswerBSmallBnumber,BhealthyBsubjects
PhaseB2BofBDrugBapprovalB-BAnswerBSmallBnumber,BsubjectsBwithBdisease
PhaseB3BofBDrugBapprovalB-BAnswerBLarge,BmultiBcenterBstudies
FDABapprovalBofBOrphanBDrugB-
BAnswerBABdrugBorBbiologicalBproductBforBtheBdiagnosisBorBtreatmentBofBaBrareBdise
ase
ABrareBdisease
DiseaseBaffectsB<200,000Bpersons
Also,BorphanBdrugBifBthereBisBnoBreasonableBexpectationBofBrecoveringBtheBcostBofBd
rugBdevelopment
RoutesBofBAdministrationB-
BAnswerBEnteral:Btablet,Bcapsule,Bsuppository,Belixir,Bsuspension
Parenteral:BIV,BIM,BSC,BIT,BIO
Transdermal:BPatch,Bpaste
Inhalation:BGas,Baerosol